Workflow
Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025
ACTUActuate Therapeutics,Inc(ACTU) GlobeNewswire·2025-04-17 20:00